News Imcivree Approved in Treatment of Two Rare Genetic Disorders April 14, 2022 Read More » Avastin Biosimilar Alymsys Granted Approval April 13, 2022 Read More » Xigduo XR Receives New Indication for Kidney Disease April 11, 2022 Read More » ArmonAir Now Indicated for Younger Patient Population April 8, 2022 Read More » Vijoice Approved to Treat Group of Rare Genetic Disorders April 6, 2022 Read More » New Acute Treatment Option for Schizophrenia and Bipolar Disorder April 6, 2022 Read More » Ardelyx Launches Irritable Bowel Syndrome Treatment Ibsrela April 4, 2022 Read More » Brand Medications with Generic Alternatives Anticipated to be Approved in April April 1, 2022 Read More » Yescarta Granted Approval for Earlier Use in B-Cell Lymphoma April 1, 2022 Read More » Page1 … Page30 Page31 Page32 Page33 Page34 … Page38 Benefit Advisors & Employees - Want to know more? Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager Full Name(Required)Email(Required) Comment(Required)Company Name(Required)CAPTCHA
Brand Medications with Generic Alternatives Anticipated to be Approved in April April 1, 2022 Read More »